iBio
IBIO
#10296
Rank
โ‚น4.84 B
Marketcap
โ‚น68.82
Share price
-4.00%
Change (1 day)
-29.41%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): -โ‚น65.34

According to iBio's latest financial reports the company's current EPS (TTM) is -โ‚น70.54. In 2025 the company made an earnings per share (EPS) of -โ‚น164.60 an increase over its 2024 EPS that were of -โ‚น611.39.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น65.34-60.3%
2025-โ‚น164.60-73.08%
2024-โ‚น611.39-93.88%
2023-โ‚น9,988-8.14%
2022-โ‚น10,87392.67%
2021-โ‚น5,644-80.33%
2020-โ‚น28,688-35.11%
2019-โ‚น44,208-38.96%
2018-โ‚น72,426-6.1%
2017-โ‚น77,12936.67%
2016-โ‚น56,43633.33%
2015-โ‚น42,32750%
2014-โ‚น28,218-53.85%
2013-โ‚น61,139-7.14%
2012-โ‚น65,842-64.1%
2011-โ‚น1,83,41777.27%
2010-โ‚น1,03,466144.44%
2009-โ‚น42,32712.93%
2008-โ‚น37,48212.2%
2007-โ‚น33,406

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น628.30-990.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-โ‚น48.91-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น630.20 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น474.06 572.00%๐Ÿ‡บ๐Ÿ‡ธ USA